2002
DOI: 10.1016/s0300-2896(02)75269-1
|View full text |Cite
|
Sign up to set email alerts
|

La toracocentesis en la evaluación del cáncer de pulmón con derrame pleural

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…In one series including 971 consecutive patients with lung cancer, Martin Diaz et al [22 ]found pleural effusion in 188 cases (19%), and only 72 of them (7%) were visible on chest X-ray films. The remaining 116 effusions were detected on CT or ultrasound examination, or were found only at thoracotomy.…”
Section: Indications For Thoracoscopymentioning
confidence: 99%
“…In one series including 971 consecutive patients with lung cancer, Martin Diaz et al [22 ]found pleural effusion in 188 cases (19%), and only 72 of them (7%) were visible on chest X-ray films. The remaining 116 effusions were detected on CT or ultrasound examination, or were found only at thoracotomy.…”
Section: Indications For Thoracoscopymentioning
confidence: 99%
“…EGFR, ALK mutations). The limited tumour tissue and cell availability, the low and variable sensitivity of cytology (ranging from 43–91%) and the significant false-negative rate in the event of insufficient cell numbers from PE provided the impetus to investigate novel, complementary diagnostic markers 4 10 24 25 26 . The utilisation of cell-free DNA from blood samples as a surrogate for tumour biopsy to determine EGFR mutation status represents one such promising alternative that is currently evaluated clinically to assist the diagnosis of NSCLC 15 16 .…”
Section: Discussionmentioning
confidence: 99%